220 related articles for article (PubMed ID: 14737822)
1. Augmenting treatment of obsessive-compulsive disorder with Antonovsky's sense of coherence theory.
Joachim B; Lyon DD; Farrell SP
Perspect Psychiatr Care; 2003; 39(4):163-8. PubMed ID: 14737822
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review.
Abramowitz JS
J Consult Clin Psychol; 1997 Feb; 65(1):44-52. PubMed ID: 9103733
[TBL] [Abstract][Full Text] [Related]
4. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
5. Treating obsessive compulsive disorder.
Veale D
Practitioner; 2002 Mar; 246(1632):181, 184-6. PubMed ID: 11901781
[No Abstract] [Full Text] [Related]
6. Obsessive-compulsive disorder: unearthing a hidden problem.
El-Sayegh S; Bea S; Agelopoulos A
Cleve Clin J Med; 2003 Oct; 70(10):824-5, 829-30, 832-3, passim. PubMed ID: 14621230
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
Varigonda AL; Jakubovski E; Bloch MH
J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
[TBL] [Abstract][Full Text] [Related]
8. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
9. Augmenting SRIs for Obsessive-Compulsive Disorder: Patient Preference for Risperidone Does Not Limit Effectiveness of Exposure and Ritual Prevention.
Wheaton MG; Carpenter JK; Kalanthroff E; Foa EB; Simpson HB
Psychother Psychosom; 2016; 85(5):314-6. PubMed ID: 27513584
[TBL] [Abstract][Full Text] [Related]
10. Processes of change in cognitive-behavioural treatment of obsessive-compulsive disorder: Current status and some future directions.
Polman A; Bouman TK; van Hout WJ; de Jong PJ; den Boer JA
Clin Psychol Psychother; 2010; 17(1):1-12. PubMed ID: 19658125
[TBL] [Abstract][Full Text] [Related]
11. Issues in the pharmacological treatment of obsessive-compulsive disorder.
Math SB; Janardhan Reddy YC
Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795
[TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.
Fineberg NA; Reghunandanan S; Simpson HB; Phillips KA; Richter MA; Matthews K; Stein DJ; Sareen J; Brown A; Sookman D;
Psychiatry Res; 2015 May; 227(1):114-25. PubMed ID: 25681005
[TBL] [Abstract][Full Text] [Related]
13. Obsessive-compulsive disorder in childhood and adolescence.
Presta S; Marazziti D; Dell'Osso L; Pfanner C; Pfanner P; Marcheschi M; Masi G; Muratori F; Mucci M; Millepiedi S; Cassano GB
Psychopathology; 2003; 36(2):55-64. PubMed ID: 12766314
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.
Hembree EA; Riggs DS; Kozak MJ; Franklin ME; Foa EB
CNS Spectr; 2003 May; 8(5):363-71, 381. PubMed ID: 12766692
[TBL] [Abstract][Full Text] [Related]
15. Individual versus group cognitive-behavioral treatment for obsessive-compulsive disorder: a controlled pilot study.
Jaurrieta N; Jimenez-Murcia S; Menchón JM; Del Pino Alonso M; Segalas C; Alvarez-Moya EM; Labad J; Granero R; Vallejo J
Psychother Res; 2008 Sep; 18(5):604-14. PubMed ID: 18816010
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
Denys D
Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723
[TBL] [Abstract][Full Text] [Related]
17. The nature, assessment, and treatment of obsessive-compulsive disorder.
McGuire JF; Lewin AB; Horng B; Murphy TK; Storch EA
Postgrad Med; 2012 Jan; 124(1):152-65. PubMed ID: 22314125
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of obsessive-compulsive disorder and related disorders.
Dell'Osso B; Altamura AC; Mundo E; Marazziti D; Hollander E
Int J Clin Pract; 2007 Jan; 61(1):98-104. PubMed ID: 17229184
[TBL] [Abstract][Full Text] [Related]
19. Increased maintenance of obsessive-compulsive disorder remission after integrated serotonergic treatment and cognitive psychotherapy compared with medication alone.
Biondi M; Picardi A
Psychother Psychosom; 2005; 74(2):123-8. PubMed ID: 15741763
[TBL] [Abstract][Full Text] [Related]
20. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
